-
effectivehealthcare.ahrq.gov/health-topics/cryptosporidiosis
-
effectivehealthcare.ahrq.gov/health-topics/aphasia
-
effectivehealthcare.ahrq.gov/health-topics/macular-degeneration
-
effectivehealthcare.ahrq.gov/health-topics/liver-transplantation
-
effectivehealthcare.ahrq.gov/health-topics/celiac-disease
-
effectivehealthcare.ahrq.gov/health-topics/pleural-disorders
-
effectivehealthcare.ahrq.gov/health-topics/e-coli-infections
-
effectivehealthcare.ahrq.gov/health-topics/infectious-arthritis
-
effectivehealthcare.ahrq.gov/health-topics/antibiotic-resistance
-
effectivehealthcare.ahrq.gov/health-topics/stomach-cancer
-
effectivehealthcare.ahrq.gov/health-topics/guillain-barre-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/bursitis
-
effectivehealthcare.ahrq.gov/health-topics/cytomegalovirus-infections
-
effectivehealthcare.ahrq.gov/health-topics/raynauds-disease
-
effectivehealthcare.ahrq.gov/health-topics/gonorrhea
-
effectivehealthcare.ahrq.gov/health-topics/rickets
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
April 18, 2017 - PTCA, CVD mortality, total
mortality)
Adjustment factors for
observational studies e.g.,
clinic, treatment
-
effectivehealthcare.ahrq.gov/health-topics/sjogrens-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/pain-relievers
-
effectivehealthcare.ahrq.gov/health-topics/shock